Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Iqvia Holdings Inc (NY: IQV )

227.33 -2.76 (-1.20%)
Streaming Delayed Price Updated: 10:06 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Iqvia Holdings Inc

< Previous 1 2 3 4 Next >
IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
NetworkNewsAudio – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Harnessing Power of Real-World Data
Via Investor Brand Network
Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner
Via Investor Brand Network
IQVIA to Announce Third-Quarter 2021 Results on October 21, 2021
From IQVIA
Via Business Wire
IQVIA to Host Financial Analyst and Investor Conference on November 16, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities
From IQVIA
Via Business Wire
Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce Productivity
From IQVIA
Via Business Wire
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
From IQVIA
Via Business Wire
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
From IQVIA
Via Business Wire
IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences
From IQVIA
Via Business Wire
IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute
From IQVIA
Via Business Wire
IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials
From IQVIA
Via Business Wire
Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
From IQVIA
Via Business Wire
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
From IQVIA
Via Business Wire
Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021
From IQVIA
Via Business Wire
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
U.S. District Court Issues Favorable Decision for IQVIA Against Veeva
From IQVIA
Via Business Wire
IQVIA’s Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug
From IQVIA
Via Business Wire
Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study
From IQVIA
Via Business Wire
IQVIA Announces Connected Intelligence™
From IQVIA
Via Business Wire
IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA to Announce First-Quarter 2021 Results on April 22, 2021
From IQVIA Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.